Treatment for portal hypertension in patients with cirrhosis is based on the use of β-blockers with or without organic nitrates; however, these agents are effective in less than 50% of patients ...

Forty-six patients, 32 males and 14 females with portal hypertension and cirrhosis, were evaluated. The mean age of these patients was 48 ± 12 years (mean ± SD). In 43.5% of cases, cirrhosis ...

In addition, cirrhosis distorts the liver's structure, causing blood congestion in the portal vein and, ultimately, raising ...

announced results from its NAVIGATE trial, which evaluated belapectin in patients with Metabolic Dysfunction-Associated Steatohepatitis (MASH) cirrhosis and portal hypertension. In the pre ...

Depending on the cause of cirrhosis, your doctor may recommend certain medications, such as beta-blockers or nitrates (for portal hypertension). They may also recommend antibiotics or medications ...

Purpose Published evidence on the incidence and predictors of venous thromboembolism (VTE) in patients with cirrhosis of the liver is reviewed. Summary The frequently observed phenomenon of ...